spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  RNA interference 

 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part Of A Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2019
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Sep 2018
Dr. Jared Gollob Joins Kymera Therapeutics as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Biopharmaceuticals Licensing
 HSMN NewsFeed - 12 Aug 2016
Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Aug 2015
BrainStorm Strengthens Executive Team: Announces the Appointment of Yoram Bibring as Chief Financial Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 22 Jul 2015
Voyager Therapeutics Appoints Michael Higgins to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 8 Jun 2015
Alnylam Appoints David-Alexandre Gros, M.D., Senior Vice President, Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 2 Jul 2014
Alnylam Elects Amy Schulman to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jun 2014
Solstice Biologics Appoints Dr. Lou Tartaglia as President, Chief Executive Officer; John Borgeson Joins as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Genzyme and Alnylam Expand Collaboration on Rare Genetic Diseases
Biopharmaceuticals Licensing
 HSMN NewsFeed - 13 Jan 2014
Alnylam and Genzyme Form Transformational Alliance for RNAi Therapeutics as Genetic Medicines
Biopharmaceuticals Licensing
 HSMN NewsFeed - 6 Jan 2014
Tekmira Announces Strategic Reorganization to Strengthen Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2013
Tekmira Strengthens Development Team With Appointment of Dr. Mark Kowalski as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Aug 2013
Dicerna Secures $60 Million in Oversubscribed Series C Financing
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 3 Jun 2013
Arcturus Therapeutics Raises $1.3 Million in Series Seed Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 May 2013
Arrowhead Closes $36 Million Private Offering
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Jan 2013
Solstice Biologics Secures $18 Million Series A; Licenses RNAi Delivery Technology from UC San Diego
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Jun 2012
Alnylam Expands and Develops Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2012
Tekmira Files Motion to Dismiss in Patent Infringement Suit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 10 Feb 2012
Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2011
Silence Therapeutics Announces Appointment of Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jun 2011
Tekmira Reports Expected Answer and Amended Counterclaim is Filed by Alnylam
Biopharmaceuticals Litigation
 HSMN NewsFeed - 29 Jun 2011
Alnylam Files Answer and Counterclaim Related to Tekmira Lawsuit
Biopharmaceuticals Litigation
 HSMN NewsFeed - 13 Jun 2011
Alnylam Appoints Akshay Vaishnaw as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Mar 2011
Apthera and RXi Pharmaceuticals Announce Definitive Merger Agreement
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 31 Mar 2011
RXi Pharmaceuticals Aggressively Moves into Late-Stage Clinical Development with the Agreement to Acquire Apthera, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 16 Feb 2011
Mitomics Further Strengthens Leadership Team
Diagnostics Oncology Personnel
 HSMN NewsFeed - 9 Dec 2010
Alnylam Elects Marsha Fanucci to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Oct 2010
Dicerna Pharmaceuticals Announces Second Close of Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2010
Dicerna Closes $25 Million Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 3 Jun 2010
Philips and RXi Pharmaceuticals Sign Agreement to Jointly Research Innovative Image-Guided Therapy Concepts Based on RNAi
Biopharmaceuticals Devices Drug Delivery
 HSMN NewsFeed - 2 Jun 2010
Alnylam Strengthens Management Team with New Key Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 May 2010
Dicerna Names Douglas Fambrough as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Apr 2010
Silence Therapeutics Appoints Max Herrmann as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Apr 2010
MDRNA, Inc. Acquires Cequent Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jan 2010
Alnylam Provides Key Goals and Guidance for Next 12 to 18 Months
Biopharmaceuticals
 HSMN NewsFeed - 16 Dec 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Biopharmaceuticals Mergers & Acquisitions Personnel
 HSMN NewsFeed - 24 Nov 2009
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
Biopharmaceuticals Drug Delivery Oncology
 HSMN NewsFeed - 8 Sep 2009
MDRNA Adds June D. Ameen to Management Team as Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2009
Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Apr 2009
RXi Pharmaceuticals Appoints Richard Chin, M.D. to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Apr 2009
Traversa Therapeutics Completes Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2009
RXi Pharmaceuticals Announces an Addition, Promotions Among Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Jan 2009
Alnylam and Collaborators at Harvard Medical School Demonstrate In Vivo Silencing of Key Genes Implicated in the Transmission of Herpes Simplex Virus-2 (HSV-2)
Biopharmaceuticals
 HSMN NewsFeed - 20 Jan 2009
Alnylam Provides Update on Kreutzer-Limmer Patent Family
Biopharmaceuticals
 HSMN NewsFeed - 2 Dec 2008
BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
Diagnostics Personnel
 HSMN NewsFeed - 2 Oct 2008
Intradigm Raises $18.5 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Oct 2008
Alnylam Appoints Industry Leader John Schmidt as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2008
Regulus Therapeutics Appoints Dr. Stelios Papadopoulos to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Aug 2008
Regulus Therapeutics Appoints Garry Menzel, Ph.D., as Executive Vice President Corporate Development and Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jul 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Biopharmaceuticals Distribution
 HSMN NewsFeed - 10 Jun 2008
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jun 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Completion of Business Combination
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2008
Alnylam and Takeda Form Strategic Worldwide Platform Alliance in RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 28 Apr 2008
Alfacell Announces Retirement of Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 10 Apr 2008
Celera Grants License to Merck & Co., Inc. for Cancer Targets
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Apr 2008
Quark Pharmaceuticals, Inc. Closes $27 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Apr 2008
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Mar 2008
Tekmira Pharmaceuticals and Protiva Biotherapeutics Announce Business Combination to Create Global Leader in RNAi Delivery and Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2008
AVI BioPharma Announces Acquisition of Ercole Biotech
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Feb 2008
Regulus Therapeutics Appoints Peter S. Linsley, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2008
Traversa Raises $2M to Advance RNAi Delivery in Angel-Led Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jan 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement With BL&H for South Korea, Taiwan and Hong Kong
Biopharmaceuticals Distribution Oncology
 HSMN NewsFeed - 17 Jan 2008
Alfacell Appoints David Sidransky Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Jan 2008
Strativa Pharmaceuticals Acquires Commercialization Rights to Onconase(R) from Alfacell Corporation
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 7 Jan 2008
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2007
Alnylam Appoints Barry Greene President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Dec 2007
Regulus Therapeutics Appoints Kleanthis G. Xanthopoulos, Ph.D. as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Nov 2007
Alfacell Appoints Lawrence A. Kenyon Chief Operating Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2007
Alnylam Expands Management Team with New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
AVI BioPharma Receives Orphan Drug Designation for AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Sep 2007
Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner
Venture Capital Personnel
 HSMN NewsFeed - 19 Sep 2007
Alnylam Announces the Termination of its Collaboration with Merck & Co., Inc.
Biopharmaceuticals
 HSMN NewsFeed - 12 Sep 2007
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Sep 2007
Quark Pharmaceuticals Appoints New Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Aug 2007
Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Aug 2007
Nucleonics Challenges Dismissal of Counterclaims Against Benitec
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Aug 2007
Kylin Therapeutics Names Cancer Therapy Leader to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jul 2007
Alnylam and Medtronic Advance Collaboration on Drug-Device Combinations with RNAi Therapeutics for CNS Diseases
Biopharmaceuticals Devices Drug Delivery Neurology
 HSMN NewsFeed - 26 Jul 2007
Alfacell and US Pharmacia Announce ONCONASE(R) Distribution Agreement for Eastern Europe
Biopharmaceuticals Distribution
 HSMN NewsFeed - 24 Jul 2007
Alnylam Expands Management Team with New Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Jul 2007
Roche and Alnylam Form Major Alliance on RNAi Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 26 Jun 2007
Alnylam Initiates Phase II Clinical Trial to Evaluate Safety and Anti-viral Efficacy of ALN-RSV01 in the Treatment of Respiratory Syncytial Virus (RSV) Infection
Biopharmaceuticals
 HSMN NewsFeed - 18 Jun 2007
Cequent Pharmaceuticals Completes $9 Million Series a Financing With Equity Investment from Novartis Option Fund
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 May 2007
Intradigm Announces Addition of Samuel Zalipsky to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 May 2007
AVI BioPharma and Ercole Biotech Announce License and Drug Development Agreement for Duchenne Muscular Dystrophy and Beta Thalassemia
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2007
ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma, Reports World-Renowned Mesothelioma Researcher at AACR Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Apr 2007
Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Apr 2007
Innovative Pulmonary and PEGylation-Based Therapeutic Product Development Drives Business Strategy of Nektar Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Apr 2007
Researchers Identify Intracellular Pathway of Alfacell's ONCONASE(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Mar 2007
Acuity Pharmaceuticals and Froptix Corporation Agree to Mergers with Public Shell; New Company to Develop and Market Drugs for Disorders of the Eye
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 22 Mar 2007
Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Mar 2007
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Alnylam Announces Key Product and Business Goals for 2007
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2007
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
Regenerative Medicine Personnel
 HSMN NewsFeed - 27 Dec 2006
Protiva Dismisses, Without Prejudice, Its California Litigation Against Inex
Biopharmaceuticals Litigation
 HSMN NewsFeed - 5 Dec 2006
Alnylam Advances a Systemically Delivered RNAi Therapeutic Targeting PCSK9 for the Treatment of Hypercholesterolemia as New Development Program
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2006
Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus (RSV) Infection
Biopharmaceuticals
 HSMN NewsFeed - 21 Nov 2006
Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 14 Nov 2006
Tacere Therapeutics Appoints Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Oct 2006
Merck & Co., Inc. to Acquire Sirna Therapeutics, Inc.
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 24 Oct 2006
Acuity Pharmaceuticals Appoints Denis O'Shaughnessy Senior Vice President of Clinical Development
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Sep 2006
Alnylam Announces Management Transition Plan in Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2006
Cenix BioScience and Merck KGaA Sign Framework Agreement for RNAi-Based Drug Discovery
Biopharmaceuticals
 HSMN NewsFeed - 26 Sep 2006
Pfizer Expands Research Commitment to Ophthalmology Through Licensing Agreement With Quark Biotech
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 20 Sep 2006
Biogen Idec and Alnylam Form Alliance to Discover and Develop Therapeutics for the Potential Treatment of Progressive Multifocal Leukoencephalopathy (PML)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Sep 2006
Protiva Files Suit Against Inex in California Superior Court
Biopharmaceuticals Litigation
 HSMN NewsFeed - 8 Sep 2006
Eli Lilly and Company CEO Says Biomedical Breakthroughs Are Transforming Medicine and Promise to Radically Ease the Impact of Aging
Biopharmaceuticals
 HSMN NewsFeed - 1 Jun 2006
Acuity Pharmaceuticals Reports Positive Initial Phase II Results for Bevasiranib (Cand5) in Wet AMD
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 24 May 2006
Alnylam Grants Bioneer License to Kreutzer-Limmer Patents for the RNA Interference (RNAi) Research Products Market
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 54

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 54 additional stories matching:
RNA interference
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.